We can now see sepsis
Learn More:
Learn More:
The IntelliSep test runs on the Cytovale medical device to risk-stratify patients based on their probability of having sepsis with organ dysfunction manifesting within the first 3 days after testing. IntelliSep provides test results in around 8 minutes, enabling faster care and optimized patient outcomes.
IntelliSep is an FDA-cleared in vitro diagnostic test for adult patients with signs and symptoms of infection who present to the Emergency Department
Sepsis is an urgent medical condition requiring rapid diagnosis and treatment, with an 8% increase in mortality for every hour that treatment is delayed.1
Like heart attack and stroke, now there is an objective detection tool for sepsis.
SECTION HIDDEN
IntelliSep assesses immune activation, and provides a probability of sepsis occurring within 3 days of testing
IntelliSep assesses immune activation and provides a probability of sepsis occurring within 3 days of testing.
SOURCE: Graphic adapted from Mervyn Singer, MD, European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022.
The ability to see sepsis for the first time, upon presentation, is a groundbreaking achievement. IntelliSep helps medical experts rapidly identify patients experiencing this critical medical emergency and delivers timely, actionable information, empowering Emergency Departments to overcome clinical uncertainty and provide appropriate care.
Learn more about how IntelliSep can help your team.
1. The above represents one site’s experience with IntelliSep.